Combination therapy with bosentan and sildenafil in idiopathic pulmonary arterial hypertension von Hoeper, M.M, Faulenbach, C, Golpon, H, Winkler, J, Welte, T, Niedermeyer, J

Volltext

Bosentan treatment in patients with primary pulmonary hypertension receiving nonparenteral prostanoids von Hoeper, M.M, Taha, N, Bekjarova, A, Gatzke, R, Spiekerkoetter, E

Volltext

"Treat-to-target" in pulmonary arterial hypertension and the use of extracorporeal membrane oxygenation as a bridge to transplantation von Hoeper, M M

Volltext

Anticoagulant Therapy Is Not Associated with Long Term Outcome in Patients with Pulmonary Arterial Hypertension (PAH): Insights from the GRIPHON Study von Tapson, V.F, Channick, R, Chin, K, Di Scala, L, Farber, H, Gaine, S, Galiè, N, Ghofrani, H.A, Lang, I, McLaughlin, V, Preiss, R, Rubin, L.J, Simonneau, G, Sitbon, O, Hoeper, M.M

Volltext

OP0267 Initial Combination Therapy of Ambrisentan and Tadalafil in Connective Tissue Disease Associated Pulmonary Arterial Hypertension (CTD-PAH): Subgroup Analysis from the Ambiti... von Coghlan, J.G., Galiè, N., Barbera, J.A., Frost, A.E., Ghofrani, H.A., Hoeper, M.M., Mclaughlin, V.V., Peacock, A.J., Simonneau, G., Vachiery, J.L., Blair, C., Gillies, H., Harris, J.H., Langley, J., Rubin, L.J.

Volltext

PP-372 Characteristics of Adults with Congenital Heart Disease and Pulmonary Arterial Hypertension in the COMPERA-CHD Registry von Kaemmerer, H, Pittrow, D, Huscher, D, Tiede, H, Delcroix, M, Gorenflo, M, D'alto, M, Pujol, C, Praus, A, Engelhardt, A, Ewert, P, Hoeper, M.M

Volltext

The prognostic impact of follow-up assessments in patients with idiopathic pulmonary arterial hypertension von NICKEL, N, GOLPON, H, GREER, M, KNUDSEN, L, OLSSON, K, WESTERKAMP, V, WELTE, T, HOEPER, M. M

Volltext

Symptom Burden and Health Related Quality of Life in Patients With Idiopathic Pulmonary Fibrosis in Clinical Practice: Insights-Ipf Registry von Pittrow, D, Klotsche, J, Kreuter, M, Hoeper, M.M, Wirtz, H, Koschel, D, Claussen, M, Andreas, S, Grohé, C, Geier, S, Koppe, U, Behr, J

Volltext

Ultrasonic versus jet nebulization of iloprost in severe pulmonary hypertension von Gessler, T, Schmehl, T, Hoeper, M.M, Rose, F, Ghofrani, H.A, Olschewski, H, Grimminger, F, Seeger, W

Volltext

Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: a phase II study von GHOFRANI, H. A, HOEPER, M. M, HALANK, M, MEYER, F. J, STAEHLER, G, BEHR, J, EWERT, R, WEIMANN, G, GRIMMINGER, F

Volltext

Effects of inhaled salbutamol in primary pulmonary hypertension von Spiekerkoetter, E, Fabel, H, Hoeper, M.M

Volltext

Extracorporeal Membrane Oxygenation in Nonintubated Patients as Bridge to Lung Transplantation von Olsson, K. M., Simon, A., Strueber, M., Hadem, J., Wiesner, O., Gottlieb, J., Fuehner, T., Fischer, S., Warnecke, G., Kühn, C., Haverich, A., Welte, T., Hoeper, M. M.

Volltext

Bridge to Thoracic Organ Transplantation in Patients with Pulmonary Arterial Hypertension Using a Pumpless Lung Assist Device von Strueber, M., Hoeper, M. M., Fischer, S., Cypel, M., Warnecke, G., Gottlieb, J., Pierre, A., Welte, T., Haverich, A., Simon, A. R., Keshavjee, S.

Volltext

Chronic thromboembolic pulmonary hypertension: evaluation with 64-detector row CT vs. digital subtraction angiography von Reichelt, A, Hoeper, M.M, Galanski, M, Keberle, M

Volltext

“Treat-to-target” in pulmonary arterial hypertension and the use of extracorporeal membrane oxygenation as a bridge to transplantation: Table 1 von Hoeper, M.M.

Volltext

(16) - Waitlist Stratification and Outcomes in Lung Transplantation for Severe Pulmonary Hypertension von Kruszona, S., Aburahma, K., Franz, M., de Manna, N.D., Avsar, M., Bobylev, D., Schwerk, N., Weymann, A., Ruhparwar, A., Welte, T., Hoeper, M.M., Kuehn, C., Salman, J., Greer, M., Ius, F.

Volltext

Analysis of Risk Assessment Tools in the REPLACE Study von Benza, R.L., Simonneau, G., Ghofrani, H.A., Corris, P.A., Rosenkranz, S., Langleben, D., Chang, M., Kleinjung, F., Meier, C., Hoeper, M.M.

Volltext

423: Avoiding Mechanical Ventilation during Extracorporeal Membrane Oxygenation before Lung Transplantation Decreases Postoperative Mortality von Sommer, W, Warnecke, G, Olsson, K, Hadem, J, Hoeper, M.M, Gottlieb, J, Fegbeutel, C, Welte, T, Strueber, M, Haverich, A, Simon, A.R

Volltext

Long-term outcomes in newly diagnosed pulmonary arterial hypertension (PAH) patients receiving initial triple oral combination therapy: insights from the randomised controlled TRIT... von Galie, N, Sitbon, O, Doelberg, M, Gibbs, J.S.R, Hoeper, M.M, Martin, N, Mathai, S.C, McLaughlin, V, Perchenet, L, Simonneau, G, Chin, K

Volltext

Suppressor of Tumorigenicity 2 as a Biomarker in Pulmonary Arterial Hypertension and its Association with REVEAL Risk Score in Riociguat-Treated Patients in the RESPITE Study von Benza, R.L., Klinger, J.R., Ghofrani, H.A., Jansa, P., Grünig, E., Vizza, D., Hoeper, M.M.

Volltext